David Launay

Latest

• Absence of functional autoantibodies in systemic sclerosis: is now the right time to broaden reactome analysis? Comment on the article by van Oostveen et al
• Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysis
• Autoreactive B cells in autoimmune diseases: Mechanisms, functions and clinical implications
• Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players
• Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR Trials
• Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells
• Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patients
• Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participants
• Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study
• Analysis of Unfolded Protein Response Activation in Colon Adenocarcinoma Epithelial Cells: A Proteomic Study
• Comparative Analysis of Laboratory-Scale Immunoglobulin G Purification Methods from Human Serum
• Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis
• Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study
• Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study
• Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis
• Perception of aesthetic impairment in patients with systemic sclerosis determined using a semi-quantitative scale and its association with disease characteristics
• Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study
• Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisis
• Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis
• Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?
• Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study
• Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme
• Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial
• Perception of aesthetic impairment in patients with systemic sclerosis using a semi-quantitative scale and association with disease characteristics.
• Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality
• Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis
• Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension
• Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients
• Simple gene signature to assess murine fibroblast polarization
• Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics Study
• Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
• Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up
• Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program
• Multi-view Clustering of Heterogeneous Health Data: Application to Systemic Sclerosis
• Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study
• The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial
• Passages in culture and stimulation conditions influence protein expression of primary fibroblasts
• French recommendations for the management of systemic sclerosis
• Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension
• Perception of Aesthetic Impairment in Patients With Systemic Sclerosis: A Case Control Study Using a Semi-Quantitative Scale for Body Image Assessment.
• 18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
• Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study
• Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study
• Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools
• Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
• Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors
• Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors
• Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients
• Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatment
• Clinical Characteristics and Outcome of Patients with Infective Endocarditis Diagnosed in a Department of Internal Medicine
• Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis
• Serious Infectious Events and Immunoglobulin Replacement Therapy in Patients With Autoimmune Disease Receiving Rituximab: A Retrospective Cohort Study
• Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort
• Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
• Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross‐Sectional Study
• Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis
• Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis
• Hypertension pulmonaire et connectivites
• Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
• Altered B lymphocyte homeostasis and functions in systemic sclerosis
• Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus
• Factors associated with the 6-minute walk distance in patients with systemic sclerosis
• Pulmonary hypertension in systemic sclerosis: different phenotypes
• Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease
• B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis
• Special considerations in pregnant systemic sclerosis patients
• Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
• An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies
• Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity
• Prevalence of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: New Data From a French Cohort and a Systematic Review and Meta‐Analysis
• Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
• Survival and Prognostic Factors in Systemic Sclerosis–Associated Pulmonary Hypertension: A Systematic Review and Meta‐Analysis
• Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome